Jazz Pharmaceuticals JAZZ reported second-quarter results highlighted by total revenue of $957 million, representing a 3% increase from the prior-year period. The strong patient uptake of Xywav (the ...

DUBLIN, July 9, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that Samantha Pearce, Senior Vice President (SVP), Europe and International, has been promoted to Chief Commercial ...

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) announced the commercial availability in Canada of Zepzelca (lurbinectedin), the first new treatment in Canada for adult patients with stage III or ...

Today, Jazz Pharmaceuticals plc reported its first quarter 2026 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website along with the ...

Jazz Pharmaceuticals JAZZ reported healthy first-quarter results highlighted by total revenue of $893 million, representing a 10% increase from the prior-year period thanks to the company’s ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DUBLIN - Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has announced the promotion of Samantha Pearce to the position of Chief Commercial Officer (CCO), effective from August 1, 2024. With over three decades ...